BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8253420)

  • 1. [Dideoxynucleoside therapy in acquired immunodeficiency syndrome].
    Rahav G; Maayan S
    Harefuah; 1993 Nov; 125(9):272-9. PubMed ID: 8253420
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
    Fischl MA
    AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanding AIDS drug availability.
    Marwick C
    JAMA; 1989 Sep; 262(10):1289. PubMed ID: 2503628
    [No Abstract]   [Full Text] [Related]  

  • 4. Study results at a glance.
    AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV infection. Zidovudine and 2',3'-dideoxycytidine in AIDS].
    Walz B
    Med Monatsschr Pharm; 1988 Dec; 11(12):415. PubMed ID: 2850454
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral treatment of HIV infection.
    Thomas MG; Ellis-Pegler RB
    N Z Med J; 1995 May; 108(1000):181-2. PubMed ID: 7783984
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS treatment: 'parallel trick' for ddI.
    McGourty C
    Nature; 1989 Oct; 341(6242):474. PubMed ID: 2507927
    [No Abstract]   [Full Text] [Related]  

  • 8. Continued zidovudine or didanosine for human immunodeficiency virus infection.
    Saitz R; Friedmann PD; Roberts MS
    N Engl J Med; 1992 Nov; 327(22):1598; author reply 1599. PubMed ID: 1435891
    [No Abstract]   [Full Text] [Related]  

  • 9. Making sense of 175 and Delta.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4. PubMed ID: 11362916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the conundrums of ACTG 175 be solved? An interview with Martin S. Hirsch, MD.
    Hirsch MS
    J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):29-30. PubMed ID: 11362965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTG 175 and Delta.
    Torres G
    GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children with AIDS benefit from two-drug regimen.
    Oncology (Williston Park); 1992 Jul; 6(7):86-7. PubMed ID: 1386243
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose of doubt.
    Day M
    Nurs Times; 1994 Jul 13-19; 90(28):20. PubMed ID: 8065956
    [No Abstract]   [Full Text] [Related]  

  • 14. [The anti-viral agents used in the treatment of AIDS].
    Portet-Brunet L
    Soins; 1994 May; (584):55-7. PubMed ID: 8029731
    [No Abstract]   [Full Text] [Related]  

  • 15. New drugs being tested for better AIDS treatment.
    Ohio Med; 1991 Jan; 87(1):39. PubMed ID: 1902288
    [No Abstract]   [Full Text] [Related]  

  • 16. New trials reach same conclusion: two drugs are better than AZT alone.
    AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategies against HIV: status in 1994 and future prospectives].
    Internist (Berl); 1994 Jul; 35(7 Suppl):1-24. PubMed ID: 9131074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
    Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
    [No Abstract]   [Full Text] [Related]  

  • 19. [New therapeutic trends in AIDS].
    Perno CF; CaliĆ² R
    Clin Ter; 1992 Feb; 140(2):197-204. PubMed ID: 1314726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [AIDS studies with didanosine and stavudine].
    Dtsch Med Wochenschr; 1996 May; 121(22):A30. PubMed ID: 8646981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.